Local activation of coagulation and inhibition of fibrinolysis in the lung during ventilator associated pneumonia

Thorax. 2004 Feb;59(2):130-5. doi: 10.1136/thorax.2003.013888.

Abstract

Background: Fibrin deposition is a hallmark of pneumonia. To determine the kinetics of alterations in local coagulation and fibrinolysis in relation to ventilator associated pneumonia (VAP), a single centre prospective study of serial changes in pulmonary and systemic thrombin generation and fibrinolytic activity was conducted in patients at risk for VAP.

Methods: Non-directed bronchial lavage (NBL) was performed on alternate days in patients expected to require mechanical ventilation for more than 5 days. A total of 28 patients were studied, nine of whom developed VAP.

Results: In patients who developed VAP a significant increase in thrombin generation was observed in the airways, as reflected by a rise in the levels of thrombin-antithrombin complexes in NBL fluid accompanied by increases in soluble tissue factor and factor VIIa concentrations. The diagnosis of VAP was preceded by a decrease in fibrinolytic activity in NBL fluid. Indeed, before VAP was diagnosed clinically, plasminogen activator activity levels in NBL fluid gradually declined, which appeared to be caused by a sharp increase in NBL fluid levels of plasminogen activator inhibitor 1.

Conclusion: VAP is characterised by a shift in the local haemostatic balance to the procoagulant side, which precedes the clinical diagnosis of VAP.

MeSH terms

  • Blood Coagulation / physiology*
  • Female
  • Fibrin / antagonists & inhibitors*
  • Fibrinolysis / physiology*
  • Humans
  • Male
  • Middle Aged
  • Pneumonia / blood*
  • Pneumonia / etiology
  • Prospective Studies
  • Respiration, Artificial / adverse effects*

Substances

  • Fibrin